Susquehanna International Group, LLP Verve Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$641 Billion
Q4 2024

A detailed history of Susquehanna International Group, LLP transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 42,484 shares of VERV stock, worth $221,766. This represents 0.0% of its overall portfolio holdings.

Number of Shares

42,484

Previous 73,748 42.39%

Holding current value

$221,766

Previous $356,000 32.87%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$4.5 - $7.19 $140,688 - $224,788	-31,264 Reduced 42.39%	42,484 $239,000
Q3 2024 Nov 14, 2024	SELL	$4.4 - $7.86 $522,095 - $932,651	-118,658 Reduced 61.67%	73,748 $356,000
Q2 2024 Aug 15, 2024	BUY	$4.76 - $12.79 $665,838 - $1.79 Million	139,882 Added 266.32%	192,406 $938,000
Q1 2024 May 07, 2024	SELL	$10.81 - $17.96 $823,635 - $1.37 Million	-76,192 Reduced 59.19%	52,524 $697,000
Q4 2023 Feb 14, 2024	BUY	$8.84 - $18.7 $845,006 - $1.79 Million	95,589 Added 288.55%	128,716 $1.79 Million
Q3 2023 Nov 14, 2023	BUY	$11.42 - $20.82 $140,054 - $255,336	12,264 Added 58.78%	33,127 $439,000
Q2 2023 Aug 11, 2023	SELL	$13.34 - $19.9 $1.3 Million - $1.94 Million	-97,575 Reduced 82.38%	20,863 $391,000
Q1 2023 May 16, 2023	BUY	$14.3 - $24.01 $643,771 - $1.08 Million	45,019 Added 61.32%	118,438 $1.71 Million
Q4 2022 Feb 14, 2023	SELL	$17.85 - $40.7 $428,275 - $976,515	-23,993 Reduced 24.63%	73,419 $1.42 Million
Q3 2022 Nov 14, 2022	BUY	$15.63 - $41.49 $1.2 Million - $3.19 Million	76,802 Added 372.64%	97,412 $3.35 Million
Q2 2022 Aug 15, 2022	SELL	$11.14 - $23.17 $292,391 - $608,142	-26,247 Reduced 56.02%	20,610 $315,000
Q1 2022 May 16, 2022	SELL	$20.92 - $39.36 $217,672 - $409,540	-10,405 Reduced 18.17%	46,857 $1.07 Million
Q4 2021 Feb 14, 2022	BUY	$31.94 - $54.82 $1.83 Million - $3.14 Million	57,262 New	57,262 $2.11 Million
Q3 2021 Nov 15, 2021	SELL	$46.0 - $73.99 $1.31 Million - $2.11 Million	-28,525 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$31.92 - $60.25 $910,518 - $1.72 Million	28,525 New	28,525 $1.72 Million

Others Institutions Holding VERV

# of Institutions

179

Shares Held

76.1M

Call Options Held

70.3K

Put Options Held

194K

View Full List

About Verve Therapeutics, Inc.

Ticker VERV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,942,300
Market Cap $313M
Description
Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...

More about VERV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Verve Therapeutics, Inc. Transaction History